Development of a method for the analysis of the lists of medicines and its application for the analysis of the lists of medicines in Russia, England, and Italy

Objective: the development and approbation of the method for comparative analysis of the lists of medicines in different countries and systems of healthcare.Material and methods. Based on the open-access data on the lists of medicines published on official websites of the authorized regulators, the...

Full description

Bibliographic Details
Main Authors: V. A. Lemeshko, K. I. Matrenin, V. V. Omelyanovskiy, Yu. V. Vasilyeva, G. R. Khachatryan, L. A. Kolganov
Format: Article
Language:Russian
Published: IRBIS LLC 2021-04-01
Series:Фармакоэкономика
Subjects:
Online Access:https://www.pharmacoeconomics.ru/jour/article/view/482
_version_ 1797878872008556544
author V. A. Lemeshko
K. I. Matrenin
V. V. Omelyanovskiy
Yu. V. Vasilyeva
G. R. Khachatryan
L. A. Kolganov
author_facet V. A. Lemeshko
K. I. Matrenin
V. V. Omelyanovskiy
Yu. V. Vasilyeva
G. R. Khachatryan
L. A. Kolganov
author_sort V. A. Lemeshko
collection DOAJ
description Objective: the development and approbation of the method for comparative analysis of the lists of medicines in different countries and systems of healthcare.Material and methods. Based on the open-access data on the lists of medicines published on official websites of the authorized regulators, the authors selected the national lists of medicines of Russia, England, and Italy for the development and approbation of the method. It was proposed to use three parameters: the absolute number of medicines by international nonproprietary name (INN); the structure of the lists based on anatomical therapeutic chemical (ATC) classification; and the coverage of the indications based on the International Classification of Diseases, 10th edition (ICD-10). The results of the analysis provided grounds for the review of the approaches to the formation of the lists of medicines required for medical help in Russia, England, and Italy and reimbursed from the state budget.Results. The number of medicines by INN in the national lists of England and Italy exceeds the total number of drugs included in the list of vital essential and desirable (VED) in Russia. All the analyzed lists were characterized by an uneven distribution of medicines within the lists by the ATC groups. The lists of medicines in England and Italy significantly exceed the list of VED by the number of the included medicines by all ATC groups excluding groups J and H in comparison with Italy, and groups J and V in comparison with England. At the same time, the list of VED significantly exceeds the list in England by the number of covered indications from the ATC L group. During the approbation, the method showed to be effective and can be used for further comparative studies of the national lists of medicines.Conclusion. Non-uniform lists of medicines by ATC-codes show that each country has priority areas in their healthcare systems. The list of VED can be shorter by the absolute number of the included medicines in England and Italy but it can exceed them by the coverage of indications due to peculiarities of the procedure of the list formation (reimbursement of medicines by all the registered indications). The results of the study with the proposed method can serve for the optimization of the VED list and the analysis of therapeutic areas that are undercovered.
first_indexed 2024-04-10T02:39:55Z
format Article
id doaj.art-4d3a1b6cbab54f6e9923d643b6f8e9f2
institution Directory Open Access Journal
issn 2070-4909
2070-4933
language Russian
last_indexed 2024-04-10T02:39:55Z
publishDate 2021-04-01
publisher IRBIS LLC
record_format Article
series Фармакоэкономика
spelling doaj.art-4d3a1b6cbab54f6e9923d643b6f8e9f22023-03-13T07:48:17ZrusIRBIS LLCФармакоэкономика2070-49092070-49332021-04-0114151510.17749/2070-4909/farmakoekonomika.2021.072328Development of a method for the analysis of the lists of medicines and its application for the analysis of the lists of medicines in Russia, England, and ItalyV. A. Lemeshko0K. I. Matrenin1V. V. Omelyanovskiy2Yu. V. Vasilyeva3G. R. Khachatryan4L. A. Kolganov5Center for Expertise and Quality Control of Medical Care; Financial Research Institute; Russian Medical Academy of Continuing Professional EducationCenter for Expertise and Quality Control of Medical CareCenter for Expertise and Quality Control of Medical Care; Financial Research Institute; Russian Medical Academy of Continuing Professional EducationCenter for Expertise and Quality Control of Medical CareCenter for Expertise and Quality Control of Medical Care; Financial Research Institute; Russian Medical Academy of Continuing Professional EducationCenter for Expertise and Quality Control of Medical CareObjective: the development and approbation of the method for comparative analysis of the lists of medicines in different countries and systems of healthcare.Material and methods. Based on the open-access data on the lists of medicines published on official websites of the authorized regulators, the authors selected the national lists of medicines of Russia, England, and Italy for the development and approbation of the method. It was proposed to use three parameters: the absolute number of medicines by international nonproprietary name (INN); the structure of the lists based on anatomical therapeutic chemical (ATC) classification; and the coverage of the indications based on the International Classification of Diseases, 10th edition (ICD-10). The results of the analysis provided grounds for the review of the approaches to the formation of the lists of medicines required for medical help in Russia, England, and Italy and reimbursed from the state budget.Results. The number of medicines by INN in the national lists of England and Italy exceeds the total number of drugs included in the list of vital essential and desirable (VED) in Russia. All the analyzed lists were characterized by an uneven distribution of medicines within the lists by the ATC groups. The lists of medicines in England and Italy significantly exceed the list of VED by the number of the included medicines by all ATC groups excluding groups J and H in comparison with Italy, and groups J and V in comparison with England. At the same time, the list of VED significantly exceeds the list in England by the number of covered indications from the ATC L group. During the approbation, the method showed to be effective and can be used for further comparative studies of the national lists of medicines.Conclusion. Non-uniform lists of medicines by ATC-codes show that each country has priority areas in their healthcare systems. The list of VED can be shorter by the absolute number of the included medicines in England and Italy but it can exceed them by the coverage of indications due to peculiarities of the procedure of the list formation (reimbursement of medicines by all the registered indications). The results of the study with the proposed method can serve for the optimization of the VED list and the analysis of therapeutic areas that are undercovered.https://www.pharmacoeconomics.ru/jour/article/view/482lists of medicinesanatomical therapeutic chemical classificationdrug provisionvital and essential medicinessystem of reimbursement
spellingShingle V. A. Lemeshko
K. I. Matrenin
V. V. Omelyanovskiy
Yu. V. Vasilyeva
G. R. Khachatryan
L. A. Kolganov
Development of a method for the analysis of the lists of medicines and its application for the analysis of the lists of medicines in Russia, England, and Italy
Фармакоэкономика
lists of medicines
anatomical therapeutic chemical classification
drug provision
vital and essential medicines
system of reimbursement
title Development of a method for the analysis of the lists of medicines and its application for the analysis of the lists of medicines in Russia, England, and Italy
title_full Development of a method for the analysis of the lists of medicines and its application for the analysis of the lists of medicines in Russia, England, and Italy
title_fullStr Development of a method for the analysis of the lists of medicines and its application for the analysis of the lists of medicines in Russia, England, and Italy
title_full_unstemmed Development of a method for the analysis of the lists of medicines and its application for the analysis of the lists of medicines in Russia, England, and Italy
title_short Development of a method for the analysis of the lists of medicines and its application for the analysis of the lists of medicines in Russia, England, and Italy
title_sort development of a method for the analysis of the lists of medicines and its application for the analysis of the lists of medicines in russia england and italy
topic lists of medicines
anatomical therapeutic chemical classification
drug provision
vital and essential medicines
system of reimbursement
url https://www.pharmacoeconomics.ru/jour/article/view/482
work_keys_str_mv AT valemeshko developmentofamethodfortheanalysisofthelistsofmedicinesanditsapplicationfortheanalysisofthelistsofmedicinesinrussiaenglandanditaly
AT kimatrenin developmentofamethodfortheanalysisofthelistsofmedicinesanditsapplicationfortheanalysisofthelistsofmedicinesinrussiaenglandanditaly
AT vvomelyanovskiy developmentofamethodfortheanalysisofthelistsofmedicinesanditsapplicationfortheanalysisofthelistsofmedicinesinrussiaenglandanditaly
AT yuvvasilyeva developmentofamethodfortheanalysisofthelistsofmedicinesanditsapplicationfortheanalysisofthelistsofmedicinesinrussiaenglandanditaly
AT grkhachatryan developmentofamethodfortheanalysisofthelistsofmedicinesanditsapplicationfortheanalysisofthelistsofmedicinesinrussiaenglandanditaly
AT lakolganov developmentofamethodfortheanalysisofthelistsofmedicinesanditsapplicationfortheanalysisofthelistsofmedicinesinrussiaenglandanditaly